Filer Snapshot

Johanna Mylet

CIK 0001765988. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

10

Latest filing

08 Jan 2025

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for PSTX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 08 Jan 2025 for CIK 0001765988.

View source filing
Business address
C/O Poseida Therapeutics, Inc., 4242 Campus Point Court, Suite 700, San Diego, CA, 92121

Filer intelligence

What SEC filings say about Johanna Mylet

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for PSTX worth $0.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

PSTX

08 Jan 2025 · Chief Financial Officer

$0

Latest update

What changed recently for Johanna Mylet

Ownership report updated

Latest ownership report period: 08 Jan 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

08 Jan 2025

Page type

Ownership filings

Latest period

08 Jan 2025

Ownership context was refreshed from SEC Forms 3/4/5 filed on 08 Jan 2025.

SEC filing record

CIK 0001765988 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
10
First seen
09 Jul 2020
Latest filing
08 Jan 2025
Entity
Individual

Observed form types

4 3

Latest Filings

Showing the latest 10 of 10 SEC filings for Johanna Mylet.

4 File 001-39376

4 filing

Filing date
08 Jan 2025
Reporting date
08 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

4

Filing date
04 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
01 Mar 2022
Reporting date
01 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
22 Dec 2021
Reporting date
21 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
02 Nov 2021
Reporting date
01 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
05 Feb 2021
Reporting date
04 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
19 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
13 Jul 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-39376

FORM 3 SUBMISSION

Filing date
09 Jul 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .